Poster: CML-231 Long-Term Results of Tyrosine Kinase Inhibitors Discontinuation in Patients With Chronic Myeloid Leukemia

Clinical Lymphoma Myeloma and Leukemia(2022)

引用 0|浏览13
暂无评分
摘要
The probability of MMR loss after 5 years of follow-up was 53%. Molecular relapses were rare after 2 years without TKI therapy. However, molecular monitoring with a frequency of 2-3 times a year during long-term observation in TFR is mandatory for patients' safety, especially in those with detectable MRD.
更多
查看译文
关键词
CML,chronic myeloid leukemia,treatment-free remission,long-term follow-up
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要